-
GAAP EPS from Continuing Operations of $0.47; Adj. EPS Increases 7% to
$1.12
-
GAAP Net Income from Continuing Operations of $1.1B; Op. EBITDA Up 6%
to $4.9B
-
Net Sales Rise 5% to $21.5B, driven by Segments Within the Materials
Science and Specialty Products Divisions
-
Cost Synergy Savings of >$300MM; Run-Rate Ahead of Plan and Now on
Pace to Achieve 75% Run-Rate of $3.3B Commitment by the End of the
Third Quarter of 2018
-
DWDP Expects Op. EBITDA up ~15% in 1H18; 2Q Op. EBITDA up in all
Divisions: Ag high-30s percent; Materials Science mid-teens percent;
Specialty Products ~20%
MIDLAND, Mich. & WILMINGTON, Del.--(BUSINESS WIRE)--
DowDuPont (NYSE: DWDP):
First Quarter Financial Highlights
-
GAAP earnings per share from continuing operations was $0.47. Adjusted
earnings1 per share increased 7 percent to $1.12, compared
with pro forma adjusted earnings per share in the year-ago period of
$1.05. Adjusted earnings per share excludes significant items in the
quarter totaling net charges of $0.54 per share, as well as an $0.11
per share charge for DuPont amortization of intangible assets.
-
Net sales increased 5 percent to $21.5 billion, with growth in most
operating segments and geographic regions, from pro forma net sales of
$20.5 billion in the year-ago period. The Materials Science division
increased sales 17 percent, with double-digit gains in all segments
and gains in all regions. The Specialty Products division increased
sales 11 percent, with gains in most segments and all regions. These
increases more than offset a decline in Agriculture sales of 25
percent driven by weather-related delays to planting seasons in the
Northern Hemisphere and Brazil. Net sales included a 4 percent benefit
from currency, primarily from the Euro.
-
Volume declined 2 percent on a pro forma basis from the year-ago
period, due to a weather-related shift in Agriculture. The Materials
Science division increased volume 8 percent, with gains in most
segments and all regions. The Specialty Products division increased
volume 3 percent, with gains in all segments and most regions.
-
Local price rose 3 percent on a pro forma basis, led by increases in
all regions and most operating segments. Local price increased in each
division, led by a 5 percent increase in the Materials Science
division.
-
Operating EBITDA1 increased 6 percent on a pro forma basis
from the year-ago period to $4.9 billion. The Materials Science
division achieved 23 percent operating EBITDA growth, with
double-digit gains in all segments. The Specialty Products division
delivered 25 percent operating EBITDA growth, with double-digit gains
in most segments. Earnings drivers included local price and volume
gains in Materials Science and Specialty Products, cost synergies, a
benefit from currency, lower pension/OPEB costs2 and higher
equity earnings. These gains more than offset a decline in Agriculture
due to a weather-related shift impacting seed and crop protection
deliveries, higher feedstock costs in the other two divisions and
planned maintenance and weather-related outages in Materials Science.
-
The Company achieved cost synergy savings of more than $300 million in
the first quarter, ahead of its run-rate plan and now on pace to
deliver a 75 percent run-rate against its $3.3 billion cost synergy
commitment by the end of the third quarter of 2018.
-
DowDuPont returned nearly $2 billion to shareholders in the quarter
through dividends ($0.9 billion) and share repurchases ($1 billion).
CEO Quote
“We delivered solid first-quarter sales and operating earnings gains,
while our teams advanced the intended business separations,” said Ed
Breen, chief executive officer of DowDuPont. “The Materials Science and
Specialty Products divisions delivered better-than-expected top- and
bottom-line growth with higher prices and volume gains, including value
adding product innovations. Their growth more than offset
weather-related delays that are expected to shift a substantial portion
of our Agriculture earnings to the second quarter. All three divisions
hit their cost synergy targets, producing savings of over $300 million
as we build momentum on our $3.3 billion in cost synergies and put more
focus on the $1 billion in growth synergies. And we continue to expect
Materials Science to spin by the end of the first quarter of 2019, with
Agriculture and Specialty Products separating by June 1, 2019. These
will be three world-class companies equipped to further their leadership
positions in attractive growth markets.”
First Quarter Division Highlights
Materials Science
-
First quarter net sales increased 17 percent to $12.0 billion versus
pro forma net sales in the year-ago period, with double-digit gains in
all segments and gains in all regions. Volume grew 8 percent, local
price rose 5 percent and currency improved 4 percent.
-
First quarter Operating EBITDA grew 23 percent to $2.6 billion versus
pro forma operating EBITDA in the same quarter last year, with
double-digit gains in all segments.
-
Equity earnings improved $53 million, driven by improvements from
Sadara and the Kuwait joint ventures, which more than offset a
reduction at the Thai joint ventures and the HSC Group.
Performance Materials & Coatings
Performance Materials & Coatings reported net sales of $2.3 billion, up
12 percent versus pro forma net sales of $2.1 billion in the year-ago
period. Sales rose in all regions, with double-digit increases in Asia
Pacific and EMEA. Local price increased 9 percent, with gains in all
regions and in both businesses. Volume declined 1 percent versus the
year-ago period and currency benefited sales by 4 percent.
Consumer Solutions delivered double-digit sales growth, driven by
double-digit local price gains in most regions; disciplined price/volume
management in upstream silicone intermediate products; traction on
growth synergies; and robust demand in personal and home care
end-markets. Coatings & Performance Monomers achieved high single-digit
sales growth, driven by local price increases in all regions in response
to higher raw material costs, which more than offset a volume decline
due to supply constraints and proactive measures to shed low margin
business.
Operating EBITDA increased to $628 million, up 31 percent from pro forma
operating EBITDA of $481 million in the year-ago period, primarily due
to increased pricing, improved product mix and cost and growth synergies.
Equity earnings for the segment totaled $41 million, compared with pro
forma equity earnings of $91 million in the year-ago period. The decline
was driven by lower earnings at the HSC Group due to settlements of
long-term polysilicon sales agreements that benefited the same quarter
last year.
Industrial Intermediates & Infrastructure
Industrial Intermediates & Infrastructure reported net sales of $3.7
billion, up 30 percent versus pro forma net sales of $2.8 billion in the
year-ago period. Double-digit sales gains were reported in all regions.
Volume grew 14 percent and local price rose 11 percent. Currency
benefited sales by 5 percent.
Polyurethanes & CAV delivered robust sales growth on double-digit gains
in all regions, driven by local price gains in all regions and volume
gains in most regions. Volume growth was particularly strong in Asia
Pacific and EMEA, enabled by the contributions from new capacity at the
Sadara joint venture. Volume in North America was impacted by
weather-related unplanned outages. The business achieved price increases
and innovation-led customer wins in downstream, higher-margin systems
applications. Merchant sales of methylene diphenyl diisocyanate (MDI)
and caustic soda also expanded as a result of ongoing tightness in
industry supply/demand fundamentals. Industrial Solutions reported a
double-digit sales increase on local price gains and volume growth in
all regions, driven by new production from the Sadara joint venture. The
business reported increased demand for products used in electronic
processing and crop protection applications. The business’s volume was
also impacted by weather-related unplanned events. Construction
Chemicals delivered high single-digit sales growth, led by demand for
acrylic-based products in North America, local price increases and a
tailwind from currency, which were partly offset by a decline in methyl
cellulosics volume in EMEA due to capacity constraints.
Operating EBITDA in the first quarter was $654 million, up 28 percent
from pro forma operating EBITDA of $512 million in the year-ago period.
Pricing momentum, cost synergies and demand growth, coupled with
improved equity earnings, more than offset the impact of weather-related
outages along the U.S. Gulf Coast, higher raw material costs and
increased maintenance and turnaround activity.
Equity earnings for the segment totaled $149 million, compared with pro
forma equity earnings of $73 million in the year-ago period. The
year-over-year growth was driven by a reduction in equity losses from
the Sadara joint venture, resulting from the operation of new
facilities, and higher monoethylene glycol (MEG) pricing that benefited
the EQUATE joint venture.
Packaging & Specialty Plastics
The Packaging & Specialty Plastics segment reported net sales of $6.0
billion, up 12 percent from pro forma net sales of $5.4 billion in the
year-ago period. The sales gain was driven by volume growth of 8 percent
and a currency benefit of 4 percent, primarily in Europe. Local price
increases in ethylene derivatives were offset by declines in
hydrocarbons prices.
The Packaging and Specialty Plastics business grew volume in all regions
on broad-based demand strength, supported by new capacity additions on
the U.S. Gulf Coast and increased Sadara production. Local price was up
as increases in ethylene derivatives in the Americas more than offset
moderate declines in EMEA and Asia Pacific. Notable highlights included
double-digit sales gains in all regions, with robust demand growth in
food and specialty packaging and industrial and consumer packaging
end-markets in Asia Pacific and EMEA, as well as in rigid packaging
applications in all regions. The business also delivered strong demand
growth in elastomers applications, with double-digit volume gains in
Asia Pacific and in hot melt adhesives in EMEA.
Operating EBITDA for the segment totaled $1.3 billion, up 17 percent
from pro forma operating EBITDA of $1.1 billion in the year-ago period.
Polyethylene price increases; volume gains, including the benefit of
increased supply from growth projects; lower commissioning and startup
costs; higher equity earnings; and cost synergies more than offset
increased feedstock costs.
Equity earnings for the segment were $59 million, up from pro forma
equity earnings of $32 million in the year-ago period. Equity earnings
in the quarter benefited from a reduction in equity losses from the
Sadara joint venture, as well as improved earnings from the Kuwait joint
ventures on volume and price gains. These gains more than offset reduced
earnings at the Thai joint ventures, where rising feedstock costs
compressed margins.
Specialty Products
-
First quarter net sales increased 11 percent to $5.6 billion versus
pro forma net sales in the year-ago period, with gains in all regions
and in most segments. Volume grew 3 percent, local price rose 2
percent, currency improved 4 percent and portfolio benefited sales by
2 percent.
-
First quarter Operating EBITDA grew 25 percent to $1.6 billion versus
pro forma operating EBITDA in the same quarter last year, with gains
in all segments.
Electronics & Imaging
Electronics & Imaging delivered net sales of $1.2 billion, a decrease of
1 percent versus pro forma net sales in the year-ago period. Net sales
declined as volume growth of 1 percent, local price gains of 1 percent
and a 2 percent benefit from currency were more than offset by a
5 percent negative impact from portfolio-related actions (sales of the
Display Films and Authentication businesses).
Volume growth in the segment was driven by double-digit gains in
semiconductor and interconnect solutions, primarily in Asia Pacific.
Increased semiconductor content in end-use applications drove strong
demand in both memory and logic market segments. Continued demand for
mobile phones and other consumer electronics, as well as industrial
applications, drove volume gains in interconnect solutions. Partially
offsetting this growth was a decrease in photovoltaic and advanced
materials due to declines in trichlorosilane (TCS) as a result of supply
constraints and decreases in Tedlar® film and Solamet®
paste as module production in China slowed in the quarter. Local price
gains were driven by higher metals pricing.
Operating EBITDA for the segment was $357 million, up 9 percent from pro
forma operating EBITDA of $327 million in the year-ago period. Lower
pension/OPEB costs, cost synergies, volume growth and a benefit from
currency more than offset a negative impact from portfolio and higher
unit costs.
Nutrition & Biosciences
Nutrition & Biosciences reported net sales of $1.7 billion, an increase
of 21 percent from pro forma net sales of $1.4 billion in the year-ago
period. The increase was primarily due to a 12 percent net benefit from
portfolio, a 4 percent benefit from volume and a 4 percent benefit from
currency. Local price increased 1 percent versus the year-ago period.
The net positive impact from portfolio-related actions was due to the
acquisition of FMC’s Health & Nutrition business.
Volume growth in the segment was led by Nutrition & Health with
double-digit gains in probiotics and pharmaceuticals, coupled with
increases in systems and texturants in Asia Pacific. Growth in
probiotics was driven by increased demand in Asia Pacific and North
America. Pharmaceuticals growth was led by increased demand for
excipient applications in Asia Pacific and North America. Industrial
Biosciences volumes grew on a double-digit improvement in CleanTech led
by alkylation offerings in Asia Pacific and EMEA. Demand for microbial
control solutions in energy markets and for bioactives in home and
personal care applications also contributed to volume growth.
Operating EBITDA for the segment was $418 million, up 32 percent from
pro forma operating EBITDA of $317 million in the year-ago period driven
by a portfolio benefit, volume growth, cost synergies and lower
pension/OPEB costs, partially offset by higher costs due to growth
investments.
Transportation & Advanced Polymers
Transportation & Advanced Polymers reported net sales of $1.4 billion,
up from pro forma net sales of $1.3 billion in the year-ago period. Net
sales growth of 14 percent reflected currency benefits of 6 percent,
local price benefits of 5 percent and volume gains of 3 percent. The
growth, which came from all regions, was led by strong demand from the
transportation and electronics markets. Price increases, mainly in nylon
enterprise and polyesters, driven by Zytel®, reflected tight polymer
supply and higher feedstock costs.
Volume gains were led by Kalrez® and Vespel® high-performance solutions
as demand from the electronics and aerospace markets remained strong.
Delrin® and Hytrel® contributed to sales growth in performance resins.
Broad-based volume growth was led by Asia Pacific and North America.
Operating EBITDA for the segment totaled $437 million, an increase of 36
percent from pro forma operating EBITDA of $321 million in the year-ago
period. Lower pension/OPEB costs, favorable currency, sales gains and
cost synergies contributed to the improvement, partly offset by higher
raw material costs.
Safety & Construction
Safety and Construction delivered net sales of $1.3 billion, compared
with pro forma net sales of $1.2 billion for the year-ago period. Net
sales growth of 7 percent was driven by a currency benefit of 4 percent
and volume gains of 3 percent. Local price was even with last year’s
quarter.
Volume gains in Tyvek® reflected strength in industrial personal
protection, graphics and medical packaging. Within aramids, Nomex®
volume gains were led by composites and energy solutions, while Kevlar®
high-strength materials volume also rose amid strength in industrial
personal protection and life protection. In the construction market,
Corian® Design also rose, due to volume and favorable mix, while
building solutions declined. Volume growth in water solutions came from
reverse osmosis and ultra-filtration. Volumes were up across most
regions, with the strongest growth in Asia Pacific. Forecast estimates
remain strong from the construction market, although inclement weather
adversely impacted sales of building products in the United States and
Japan in the quarter.
Operating EBITDA for the segment totaled $354 million, an increase of 21
percent from pro forma operating EBITDA of $292 million in the year-ago
period. Lower pension/OPEB costs, cost synergies, reliability
improvements and favorable currency more than offset higher costs.
Agriculture
-
First quarter net sales decreased 25 percent to $3.8 billion versus
pro forma net sales in the year-ago period, driven by weather-related
delays in the Northern Hemisphere and Brazil seasons. Volume decreased
28 percent, local price rose 1 percent and currency improved 2 percent.
-
First quarter Operating EBITDA declined 39 percent to $891 million
versus pro forma operating EBITDA in the same quarter last year.
Volume declines were driven by weather-related delays to the start of
planting seasons in the Northern Hemisphere and Brazil, lower expected
planted area in both North America and Brazil, and lower sales in the
Brazil safrinha season due to a shift to lower-technology corn driven by
the delayed summer season harvest. Agriculture sales declines were
partially offset by improvements in sunflower seeds sales in EMEA and
growth in global insecticide sales.
Price increases were driven by continuing efforts to capture value in
established brands across the crop protection portfolio globally.
Operating EBITDA of $891 million declined 39 percent from $1.5 billion
in the prior year. Weather-related selling shifts, lower expected
planted area and an unfavorable mix driven by the shortened safrinha
season were partially offset by cost synergies, favorable currency,
higher selling price in crop protection and lower pension/OPEB costs.
Outlook
“The global economy continues to show solid momentum and broad-based
growth, driven by consumer-led demand in both developed and developing
economies,” said Howard Ungerleider, chief financial officer of
DowDuPont. “There are discrete headwinds, including continued volatility
in our input costs and weather-related softness in agriculture. However,
leading indicators from manufacturing output, to improving energy
markets, to employment and consumer spending remain largely positive,
reflecting increased economic activity.”
“Our portfolio benefits from these macro trends, and we see our
innovations and growth investments driving above-market growth. We see
this strength continuing into the second quarter. We expect second
quarter net sales to be up more than 10 percent and operating EBITDA up
more than 20 percent year-over-year.”
“Looking ahead, the DowDuPont team remains focused on our priorities:
delivering our operating and financial plan, including executing on our
growth projects and innovation launches; achieving our synergy targets;
and standing and spinning the intended companies on our stated timeline.”
Conference Call
The Company will host a live
webcast of its first quarter earnings conference call with investors
to discuss its results, business outlook and other matters today at 8:00
a.m. ET. The slide presentation that accompanies the conference call
will be posted on the DowDuPont Investor Relations events and
presentations page.
A replay of the webcast will also be available on the investor events
and presentations page of www.dow-dupont.com.
(1)
|
|
Adjusted earnings per share, Pro forma adjusted earnings per share,
Operating EBITDA and Pro forma operating EBITDA are non-GAAP
measures. See page 9 for further discussion. First quarter 2017
information is on a pro forma basis and was determined in accordance
with Article 11 of Regulation S-X.
|
(2)
|
|
Pension/OPEB (other post employment benefit plans) costs include all
components of net periodic benefit cost from continuing operations.
|
|
|
|
About DowDuPont™
DowDuPont (NYSE: DWDP) is a holding company comprised of The Dow
Chemical Company and DuPont with the intent to form strong, independent,
publicly traded companies in agriculture, materials science and
specialty products sectors that will lead their respective industries
through productive, science-based innovation to meet the needs of
customers and help solve global challenges. For more information, please
visit us at www.dow-dupont.com.
Cautionary Statement About Forward-Looking Statements
This communication contains “forward-looking statements” within the
meaning of the federal securities laws, including Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. In this context, forward-looking
statements often address expected future business and financial
performance and financial condition, and often contain words such as
“expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,”
“will,” “would,” “target,” and similar expressions and variations or
negatives of these words.
On December 11, 2015, The Dow Chemical Company (“Dow”) and E. I. du Pont
de Nemours and Company (“DuPont”) entered into an Agreement and Plan of
Merger, as amended on March 31, 2017, (the “Merger Agreement”) under
which the companies would combine in an all-stock merger of equals
transaction (the “Merger”). Effective August 31, 2017, the Merger was
completed and each of Dow and DuPont became subsidiaries of DowDuPont
(Dow and DuPont, and their respective subsidiaries, collectively
referred to as the "Subsidiaries").
Forward-looking statements by their nature address matters that are, to
varying degrees, uncertain, including the intended separation, subject
to approval of the Company’s Board of Directors and customary closing
conditions of DowDuPont’s agriculture, materials science and specialty
products businesses in one or more tax-efficient transactions on
anticipated terms (the “Intended Business Separations”). Forward-looking
statements are not guarantees of future performance and are based on
certain assumptions and expectations of future events which may not be
realized. Forward-looking statements also involve risks and
uncertainties, many of which are beyond the Company’s control. Some of
the important factors that could cause DowDuPont’s, Dow’s or DuPont’s
actual results to differ materially from those projected in any such
forward-looking statements include, but are not limited to: (i) costs to
achieve and achieving the successful integration of the respective
agriculture, materials science and specialty products businesses of Dow
and DuPont, anticipated tax treatment, unforeseen liabilities, future
capital expenditures, revenues, expenses, earnings, productivity
actions, economic performance, indebtedness, financial condition,
losses, future prospects, business and management strategies for the
management, expansion and growth of the combined operations; (ii) costs
to achieve and achievement of the anticipated synergies by the combined
agriculture, materials science and specialty products businesses; (iii)
risks associated with the Intended Business Separations, including
conditions which could delay, prevent or otherwise adversely affect the
proposed transactions, including possible issues or delays in obtaining
required regulatory approvals or clearances related to the Intended
Business Separations, associated costs, disruptions in the financial
markets or other potential barriers; (iv) disruptions or business
uncertainty, including from the Intended Business Separations, could
adversely impact DowDuPont’s business (either directly or as conducted
by and through Dow or DuPont), or financial performance and its ability
to retain and hire key personnel; (v) uncertainty as to the long-term
value of DowDuPont common stock; and (vi) risks to DowDuPont’s, Dow’s
and DuPont’s business, operations and results of operations from: the
availability of and fluctuations in the cost of energy and feedstocks;
balance of supply and demand and the impact of balance on prices;
failure to develop and market new products and optimally manage product
life cycles; ability, cost and impact on business operations, including
the supply chain, of responding to changes in market acceptance, rules,
regulations and policies and failure to respond to such changes; outcome
of significant litigation, environmental matters and other commitments
and contingencies; failure to appropriately manage process safety and
product stewardship issues; global economic and capital market
conditions, including the continued availability of capital and
financing, as well as inflation, interest and currency exchange rates;
changes in political conditions, including trade wars and retaliatory
actions; business or supply disruptions; security threats, such as acts
of sabotage, terrorism or war, natural disasters and weather events and
patterns which could result in a significant operational event for the
Company, adversely impact demand or production; ability to discover,
develop and protect new technologies and to protect and enforce the
Company’s intellectual property rights; failure to effectively manage
acquisitions, divestitures, alliances, joint ventures and other
portfolio changes; unpredictability and severity of catastrophic events,
including, but not limited to, acts of terrorism or outbreak of war or
hostilities, as well as management’s response to any of the
aforementioned factors. These risks are and will be more fully discussed
in the current, quarterly and annual reports filed with the U. S.
Securities and Exchange Commission by DowDuPont. While the list of
factors presented here is, considered representative, no such list
should be considered to be a complete statement of all potential risks
and uncertainties. Unlisted factors may present significant additional
obstacles to the realization of forward-looking statements. Consequences
of material differences in results as compared with those anticipated in
the forward-looking statements could include, among other things,
business disruption, operational problems, financial loss, legal
liability to third parties and similar risks, any of which could have a
material adverse effect on DowDuPont’s, Dow’s or DuPont’s consolidated
financial condition, results of operations, credit rating or liquidity.
None of DowDuPont, Dow or DuPont assumes any obligation to publicly
provide revisions or updates to any forward-looking statements whether
as a result of new information, future developments or otherwise, should
circumstances change, except as otherwise required by securities and
other applicable laws. A detailed discussion of some of the significant
risks and uncertainties which may cause results and events to differ
materially from such forward-looking statements is included in the
section titled “Risk Factors” (Part I, Item 1A) of DowDuPont’s 2017
annual report on Form 10-K.
The Dow Diamond, DuPont Oval logo, DuPont™, the DowDuPont logo and all
products, unless otherwise noted, denoted with ™, ℠ or ® are trademarks,
service marks or registered trademarks of The Dow Chemical Company, E.
I. du Pont de Nemours and Company, DowDuPont Inc. or their affiliates.
Supplemental unaudited pro forma information for DowDuPont is presented
to illustrate the estimated effects of the Merger, assuming that the
Merger had been consummated on January 1, 2016. For 2017, activity prior
to August 31, 2017 (the “Merger Date”) was prepared on a pro forma basis
and activity after the Merger Date was prepared on a combined U.S. GAAP
basis. The unaudited pro forma information was prepared in accordance
with Article 11 of Regulation S-X. Pro forma adjustments have been made
for (1) the preliminary purchase accounting impact, (2) accounting
policy alignment, (3) eliminate the effect of events that are directly
attributable to the Merger Agreement (e.g., one-time transaction costs),
(4) eliminate the impact of transactions between Dow and DuPont, and
(5) eliminate the effect of consummated or probable and identifiable
divestitures agreed to with certain regulatory agencies as a condition
of approval for the Merger. Events that are not expected to have a
continuing impact on the combined results (e.g., inventory step-up
costs) are excluded. The unaudited pro forma information does not
reflect restructuring or integration activities or other costs following
the Merger that may be incurred to achieve cost or growth synergies of
DowDuPont. The unaudited pro forma financial information provides
shareholders with summary financial information and historical data that
is on a basis consistent with how DowDuPont reports current financial
information.
Discussion of revenue, operating EBITDA and price/volume metrics on a
divisional basis for Agriculture is based on the results of the
Agriculture segment; for Materials Science is based on the combined
results of the Performance Materials & Coatings, Industrial
Intermediates & Infrastructure, and Packaging & Specialty Plastics
segments; and for Specialty Products is based on the combined results of
the Electronics & Imaging, Nutrition & Biosciences, Transportation &
Advanced Polymers, and Safety & Construction segments. The divisional
discussions are for informational purposes only and do not purport to be
indicative of results, including on a pro forma basis, for each of
Agriculture, Materials Science and Specialty Products on a standalone
basis as if the Intended Business Separations had already occurred.
Furthermore, the divisional discussions should not be construed as
representative of future results of operations or financial condition
for each of Agriculture, Materials Science and Specialty Products on a
standalone basis in connection with the Intended Business Separations.
Merger of Equals
Effective August 31, 2017, pursuant to the merger of equals transaction
contemplated by the Agreement and Plan of Merger, dated as of December
11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), The Dow
Chemical Company ("Dow") and E. I. du Pont de Nemours & Company
("DuPont") each merged with subsidiaries of DowDuPont Inc. ("DowDuPont"
or the "Company") and, as a result, Dow and DuPont became subsidiaries
of DowDuPont Inc. (the "Merger"). Dow was determined to be the
accounting acquirer in the Merger and, as a result, the historical
financial statements of Dow, prepared under U.S. generally accepted
accounting principles ("U.S. GAAP"), for the periods prior to the Merger
are considered to be the historical financial statements of DowDuPont.
Unaudited Pro Forma Financial Information
In order to provide the most meaningful comparison of results of
operations and results by segment, supplemental unaudited pro forma
financial information has been included in the following financial
schedules. The unaudited pro forma financial information is based on the
historical consolidated financial statements and accompanying notes of
both Dow and DuPont and has been prepared to illustrate the effects of
the Merger, assuming the Merger had been consummated on January 1, 2016.
For the three months ended March 31, 2017, pro forma adjustments have
been made for (1) the preliminary purchase accounting impact, (2)
accounting policy alignment, (3) the elimination of the effect of events
that are directly attributable to the Merger Agreement (e.g., one-time
transaction costs), (4) the elimination of the impact of transactions
between Dow and DuPont, and (5) the elimination of the effect of
consummated divestitures agreed to with certain regulatory agencies as a
condition of approval for the Merger. The unaudited pro forma financial
information was based on and should be read in conjunction with the
separate historical financial statements and accompanying notes
contained in each of the Dow and DuPont Quarterly Reports on Form 10-Q
for the quarter ended March 31, 2017. The pro forma financial
information was prepared in accordance with Article 11 of Regulation
S-X. The results for the three months ended March 31, 2018, are
presented on a U.S. GAAP basis.
The unaudited pro forma financial information has been presented for
informational purposes only and is not necessarily indicative of what
DowDuPont's results of operations actually would have been had the
Merger been completed as of January 1, 2016, nor is it indicative of the
future operating results of DowDuPont. The unaudited pro forma
information does not reflect restructuring or integration activities or
other costs following the Merger that may be incurred to achieve cost or
growth synergies of DowDuPont. For further information on the unaudited
pro forma financial information, please refer to the Company's Current
Report on Form 8-K dated October 26, 2017.
Non-GAAP Financial Measures
This earnings release includes information that does not conform to U.S.
GAAP and are considered non-GAAP measures. These measures include the
Company's pro forma consolidated results and pro forma earnings per
share on an adjusted basis. Management uses these measures internally
for planning, forecasting and evaluating the performance of the
Company's segments, including allocating resources. DowDuPont's
management believes that these non-GAAP measures best reflect the
ongoing performance of the Company during the periods presented and
provide more relevant and meaningful information to investors as they
provide insight with respect to ongoing operating results of the Company
and a more useful comparison of year-over-year results. These non-GAAP
measures supplement the Company's U.S. GAAP disclosures and should not
be viewed as an alternative to U.S. GAAP measures of performance.
Furthermore, such non-GAAP measures may not be consistent with similar
measures provided or used by other companies. Non-GAAP measures included
in this release are defined below. Reconciliations for these non-GAAP
measures to GAAP are provided in the Selected Financial Information and
Non-GAAP Measures starting on page 15. DowDuPont does not provide
forward-looking U.S. GAAP financial measures or a reconciliation of
forward-looking non-GAAP financial measures to the most comparable U.S.
GAAP financial measures on a forward-looking basis because the Company
is unable to predict with reasonable certainty the ultimate outcome of
pending litigation, unusual gains and losses, foreign currency exchange
gains or losses, potential future asset impairments and purchase
accounting fair value adjustments, as well as discrete taxable events,
without unreasonable effort. These items are uncertain, depend on
various factors, and could have a material impact on U.S. GAAP results
for the guidance period.
Adjusted earnings per share is defined as "Earnings per common share
from continuing operations - diluted" excluding the after-tax impact of
significant items and the after-tax impact of amortization expense
associated with DuPont's intangible assets. Pro forma adjusted earnings
per share is defined as "Pro Forma earnings per common share from
continuing operations - diluted" excluding the after-tax impact of pro
forma significant items and the after-tax impact of pro forma
amortization expense associated with DuPont's intangible assets.
Although amortization of DuPont's intangible assets is excluded from
these non-GAAP measures, management believes it is important for
investors to understand that such intangible assets contribute to
revenue generation. Amortization of intangible assets that relate to
past acquisitions will recur in future periods until such intangible
assets have been fully amortized. Any future acquisitions may result in
amortization of additional intangible assets.
Operating EBITDA is defined as earnings (i.e., "Income from continuing
operations before income taxes") before interest, depreciation,
amortization and foreign exchange gains (losses), excluding the impact
of significant items. Pro forma operating EBITDA is defined as pro forma
earnings (i.e., "Pro Forma income from continuing operations before
income taxes") before interest, depreciation, amortization and foreign
exchange gains (losses), excluding the impact of significant items.
Discussion of segment revenue, operating EBITDA and price/volume metrics
on a divisional basis for Agriculture is based on the results of the
Agriculture segment; for Materials Science is based on the combined
results of the Performance Materials & Coatings segment, the Industrial
Intermediates & Infrastructure segment and the Packaging & Specialty
Plastics segment; and for Specialty Products is based on the combined
results of the Electronics & Imaging segment, the Nutrition and
Biosciences segment, the Transportation & Advanced Polymers segment and
the Safety & Construction segment. The Corporate segment is not included
in the division metrics. The segment disclosures have been presented in
this manner for informational purposes only and should not be viewed as
an indication of each division’s current or future operating results on
a standalone basis assuming completion of the Intended Business
Separations.
|
|
|
|
DowDuPont Inc.
|
Consolidated Statements of Income
|
|
|
|
|
In millions, except per share amounts (Unaudited)
|
|
Three Months Ended
|
|
Mar 31,
2018
|
|
|
Mar 31,
2017
|
Net sales
|
|
$
|
21,510
|
|
|
$
|
13,230
|
|
Cost of sales
|
|
16,315
|
|
|
10,194
|
|
Research and development expenses
|
|
768
|
|
|
419
|
|
Selling, general and administrative expenses
|
|
1,714
|
|
|
759
|
|
Amortization of intangibles
|
|
474
|
|
|
155
|
|
Restructuring and asset related charges (credits) - net
|
|
262
|
|
|
(1
|
)
|
Integration and separation costs
|
|
457
|
|
|
109
|
|
Equity in earnings of nonconsolidated affiliates
|
|
257
|
|
|
196
|
|
Sundry income (expense) - net
|
|
115
|
|
|
(444
|
)
|
Interest expense and amortization of debt discount
|
|
350
|
|
|
219
|
|
Income from continuing operations before income taxes
|
|
1,542
|
|
|
1,128
|
|
Provision for income taxes on continuing operations
|
|
389
|
|
|
213
|
|
Income from continuing operations, net of tax
|
|
1,153
|
|
|
915
|
|
Loss from discontinued operations, net of tax
|
|
(5
|
)
|
|
—
|
|
Net income
|
|
1,148
|
|
|
915
|
|
Net income attributable to noncontrolling interests
|
|
44
|
|
|
27
|
|
Net income available for DowDuPont Inc. common stockholders
|
|
$
|
1,104
|
|
|
$
|
888
|
|
|
|
|
|
|
|
Per common share data:
|
|
|
|
|
|
Earnings per common share from continuing operations - basic
|
|
$
|
0.47
|
|
|
$
|
0.74
|
|
Loss per common share from discontinued operations - basic
|
|
—
|
|
|
—
|
|
Earnings per common share - basic
|
|
$
|
0.47
|
|
|
$
|
0.74
|
|
Earnings per common share from continuing operations - diluted
|
|
$
|
0.47
|
|
|
$
|
0.72
|
|
Loss per common share from discontinued operations - diluted
|
|
—
|
|
|
—
|
|
Earnings per common share - diluted
|
|
$
|
0.47
|
|
|
$
|
0.72
|
|
|
|
|
|
|
|
Dividends declared per share of common stock
|
|
$
|
0.38
|
|
|
$
|
0.46
|
|
Weighted-average common shares outstanding - basic
|
|
2,317.0
|
|
|
1,202.5
|
|
Weighted-average common shares outstanding - diluted
|
|
2,334.3
|
|
|
1,222.1
|
|
Note:
|
|
The consolidated statement of income for the three months ended
March 31, 2018, reflects the results of Dow and DuPont and the
consolidated statement of income for the three months ended March
31, 2017, reflects the results of Dow.
|
|
|
|
|
|
|
DowDuPont Inc.
|
Consolidated Balance Sheets
|
|
|
|
|
|
|
In millions, except per share amounts (Unaudited)
|
|
Mar 31,
2018
|
|
|
Dec 31,
2017
|
Assets
|
|
|
|
|
|
Current Assets
|
|
|
|
|
|
Cash and cash equivalents (variable interest entities restricted -
2018: $140; 2017: $107)
|
|
$
|
10,281
|
|
|
$
|
13,438
|
|
Marketable securities
|
|
257
|
|
|
956
|
|
Accounts and notes receivable:
|
|
|
|
|
|
Trade (net of allowance for doubtful receivables - 2018: $171; 2017:
$127)
|
|
14,378
|
|
|
11,314
|
|
Other
|
|
5,410
|
|
|
5,579
|
|
Inventories
|
|
17,457
|
|
|
16,992
|
|
Other current assets
|
|
1,950
|
|
|
1,614
|
|
Total current assets
|
|
49,733
|
|
|
49,893
|
|
Investments
|
|
|
|
|
|
Investment in nonconsolidated affiliates
|
|
5,182
|
|
|
5,336
|
|
Other investments (investments carried at fair value - 2018: $1,697;
2017: $1,512)
|
|
2,633
|
|
|
2,564
|
|
Noncurrent receivables
|
|
692
|
|
|
680
|
|
Total investments
|
|
8,507
|
|
|
8,580
|
|
Property
|
|
|
|
|
|
Property
|
|
74,329
|
|
|
73,304
|
|
Less accumulated depreciation
|
|
38,253
|
|
|
37,057
|
|
Net property (variable interest entities restricted - 2018: $869;
2017: $907)
|
|
36,076
|
|
|
36,247
|
|
Other Assets
|
|
|
|
|
|
Goodwill
|
|
60,493
|
|
|
59,527
|
|
Other intangible assets (net of accumulated amortization - 2018:
$6,024; 2017: $5,550)
|
|
32,966
|
|
|
33,274
|
|
Deferred income tax assets
|
|
1,754
|
|
|
1,869
|
|
Deferred charges and other assets
|
|
2,912
|
|
|
2,774
|
|
Total other assets
|
|
98,125
|
|
|
97,444
|
|
Total Assets
|
|
$
|
192,441
|
|
|
$
|
192,164
|
|
Liabilities and Equity
|
|
|
|
|
|
Current Liabilities
|
|
|
|
|
|
Notes payable
|
|
$
|
2,411
|
|
|
$
|
1,948
|
|
Long-term debt due within one year
|
|
2,707
|
|
|
2,067
|
|
Accounts payable:
|
|
|
|
|
|
Trade
|
|
8,754
|
|
|
9,134
|
|
Other
|
|
4,376
|
|
|
3,727
|
|
Income taxes payable
|
|
889
|
|
|
843
|
|
Accrued and other current liabilities
|
|
7,480
|
|
|
8,409
|
|
Total current liabilities
|
|
26,617
|
|
|
26,128
|
|
Long-Term Debt (variable interest entities nonrecourse - 2018: $225;
2017: $249)
|
|
29,343
|
|
|
30,056
|
|
Other Noncurrent Liabilities
|
|
|
|
|
|
Deferred income tax liabilities
|
|
6,113
|
|
|
6,266
|
|
Pension and other postretirement benefits - noncurrent
|
|
18,225
|
|
|
18,581
|
|
Asbestos-related liabilities - noncurrent
|
|
1,207
|
|
|
1,237
|
|
Other noncurrent obligations
|
|
8,012
|
|
|
7,969
|
|
Total other noncurrent liabilities
|
|
33,557
|
|
|
34,053
|
|
Stockholders' Equity
|
|
|
|
|
|
Common stock (authorized 5,000,000,000 shares of $0.01 par value
each; issued 2018: 2,348,787,059 shares; 2017: 2,341,455,518
shares)
|
|
23
|
|
|
23
|
|
Additional paid-in capital
|
|
81,518
|
|
|
81,257
|
|
Retained earnings
|
|
29,366
|
|
|
29,211
|
|
Accumulated other comprehensive loss
|
|
(7,497
|
)
|
|
(8,972
|
)
|
Unearned ESOP shares
|
|
(150
|
)
|
|
(189
|
)
|
Treasury stock at cost (2018: 28,241,499 shares; 2017: 14,123,049
shares)
|
|
(2,000
|
)
|
|
(1,000
|
)
|
DowDuPont's stockholders' equity
|
|
101,260
|
|
|
100,330
|
|
Noncontrolling interests
|
|
1,664
|
|
|
1,597
|
|
Total equity
|
|
102,924
|
|
|
101,927
|
|
Total Liabilities and Equity
|
|
$
|
192,441
|
|
|
$
|
192,164
|
|
|
|
|
|
DowDuPont Inc.
|
Pro Forma Consolidated Statements of Income
|
|
|
|
|
|
|
Three Months Ended
|
In millions, except per share amounts (Unaudited)
|
|
Mar 31,
2018
|
|
Mar 31,
2017
|
|
As Reported
|
|
Pro Forma
|
Net sales
|
|
$
|
21,510
|
|
$
|
20,467
|
|
Cost of sales 1 |
|
16,315
|
|
14,433
|
|
Research and development expenses 1 |
|
768
|
|
781
|
|
Selling, general and administrative expenses 1 |
|
1,714
|
|
1,810
|
|
Amortization of intangibles
|
|
474
|
|
428
|
|
Restructuring and asset related charges - net
|
|
262
|
|
151
|
|
Integration and separation costs
|
|
457
|
|
242
|
|
Equity in earnings of nonconsolidated affiliates
|
|
257
|
|
208
|
|
Sundry income (expense) - net 1 |
|
115
|
|
(347
|
)
|
Interest expense and amortization of debt discount
|
|
350
|
|
273
|
|
Income from continuing operations before income taxes
|
|
1,542
|
|
2,210
|
|
Provision for income taxes on continuing operations
|
|
389
|
|
281
|
|
Income from continuing operations, net of tax
|
|
1,153
|
|
1,929
|
|
Net income attributable to noncontrolling interests
|
|
44
|
|
37
|
|
Net income from continuing operations available for DowDuPont Inc.
common stockholders
|
|
$
|
1,109
|
|
$
|
1,892
|
|
|
|
|
|
|
Per common share data:
|
|
|
|
|
Earnings per common share from continuing operations - basic
|
|
$
|
0.47
|
|
$
|
0.82
|
|
Earnings per common share from continuing operations - diluted
|
|
$
|
0.47
|
|
$
|
0.81
|
|
|
|
|
|
|
Weighted-average common shares outstanding - basic
|
|
2,317.0
|
|
2,315.7
|
|
Weighted-average common shares outstanding - diluted
|
|
2,334.3
|
|
2,341.2
|
|
1.
|
|
Amounts shown in the pro forma consolidated statement of income for
the three months ended March 31, 2017, have been updated from the
Company's Current Report on Form 8-K dated October 26, 2017, to
reflect reclassifications required under Accounting Standards Update
2017-07, "Compensation - Retirement Benefits (Topic 715): Improving
the Presentation of Net Periodic Pension Cost and Net Periodic
Postretirement Benefit Cost," which was adopted on January 1, 2018
and required retrospective application.
|
|
|
|
DowDuPont Inc.
|
Net Sales by Segment and Geographic Region
|
|
|
|
Net Sales by Segment and Geographic Region
|
|
Three Months Ended
|
|
|
Mar 31, 2018
|
|
Mar 31, 2017
|
In millions (Unaudited)
|
|
As Reported
|
|
Pro Forma
|
Agriculture
|
|
$
|
3,808
|
|
$
|
5,049
|
Performance Materials & Coatings
|
|
2,304
|
|
2,063
|
Industrial Intermediates & Infrastructure
|
|
3,715
|
|
2,847
|
Packaging & Specialty Plastics
|
|
6,010
|
|
5,382
|
Electronics & Imaging
|
|
1,153
|
|
1,164
|
Nutrition & Biosciences
|
|
1,720
|
|
1,424
|
Transportation & Advanced Polymers
|
|
1,425
|
|
1,251
|
Safety & Construction
|
|
1,299
|
|
1,213
|
Corporate
|
|
76
|
|
74
|
Total
|
|
$
|
21,510
|
|
$
|
20,467
|
U.S. & Canada
|
|
$
|
7,909
|
|
$
|
8,715
|
EMEA 1 |
|
6,919
|
|
5,808
|
Asia Pacific
|
|
4,790
|
|
4,074
|
Latin America
|
|
1,892
|
|
1,870
|
Total
|
|
$
|
21,510
|
|
$
|
20,467
|
|
|
|
Pro Forma Net Sales Variance by Segment, Geographic Region and
Division
|
|
Three Months Ended Mar 31, 2018
|
|
Local
Price &
Product
Mix
|
|
Currency
|
|
Volume
|
|
Portfolio /
Other
2
|
|
Total
|
Percent change from prior year
|
|
|
|
|
|
Agriculture
|
|
1
|
%
|
|
2
|
%
|
|
(28
|
)%
|
|
—
|
%
|
|
(25
|
)%
|
Performance Materials & Coatings
|
|
9
|
|
|
4
|
|
|
(1
|
)
|
|
—
|
|
|
12
|
|
Industrial Intermediates & Infrastructure
|
|
11
|
|
|
5
|
|
|
14
|
|
|
—
|
|
|
30
|
|
Packaging & Specialty Plastics
|
|
—
|
|
|
4
|
|
|
8
|
|
|
—
|
|
|
12
|
|
Electronics & Imaging
|
|
1
|
|
|
2
|
|
|
1
|
|
|
(5
|
)
|
|
(1
|
)
|
Nutrition & Biosciences
|
|
1
|
|
|
4
|
|
|
4
|
|
|
12
|
|
|
21
|
|
Transportation & Advanced Polymers
|
|
5
|
|
|
6
|
|
|
3
|
|
|
—
|
|
|
14
|
|
Safety & Construction
|
|
—
|
|
|
4
|
|
|
3
|
|
|
—
|
|
|
7
|
|
Total
|
|
3
|
%
|
|
4
|
%
|
|
(2
|
)%
|
|
—
|
%
|
|
5
|
%
|
U.S. & Canada
|
|
2
|
%
|
|
—
|
%
|
|
(12
|
)%
|
|
1
|
%
|
|
(9
|
)%
|
EMEA 1 |
|
4
|
|
|
11
|
|
|
3
|
|
|
1
|
|
|
19
|
|
Asia Pacific
|
|
3
|
|
|
3
|
|
|
12
|
|
|
—
|
|
|
18
|
|
Latin America
|
|
5
|
|
|
—
|
|
|
(5
|
)
|
|
1
|
|
|
1
|
|
Total
|
|
3
|
%
|
|
4
|
%
|
|
(2
|
)%
|
|
—
|
%
|
|
5
|
%
|
Agriculture
|
|
1
|
%
|
|
2
|
%
|
|
(28
|
)%
|
|
—
|
%
|
|
(25
|
)%
|
Materials Science
|
|
5
|
|
|
4
|
|
|
8
|
|
|
—
|
|
|
17
|
|
Specialty Products
|
|
2
|
|
|
4
|
|
|
3
|
|
|
2
|
|
|
11
|
|
Total
|
|
3
|
%
|
|
4
|
%
|
|
(2
|
)%
|
|
—
|
%
|
|
5
|
%
|
1.
|
|
Europe, Middle East and Africa.
|
2.
|
|
Pro forma net sales for Agriculture excludes sales related to the
November 30, 2017, divestiture of a portion of Dow AgroSciences'
corn seed business in Brazil for the period January 1, 2017 through
March 31, 2017. Pro forma net sales for Packaging & Specialty
Plastics excludes sales related to the September 1, 2017,
divestiture of the global Ethylene Acrylic Acid ("EAA") copolymers
and ionomers business for the period January 1, 2017 through March
31, 2017. Portfolio & Other includes sales for the acquisition of
the H&N Business acquired on November 1, 2017, impacting Nutrition &
Biosciences. Portfolio & Other also reflects the following
divestitures: SKC Haas Display Films group of companies (divested
June 30, 2017) and the authentication business (divested on January
6, 2017), both impacting Electronics & Imaging; and, the divestiture
of the global food safety diagnostic business (divested February 28,
2017), impacting Nutrition & Biosciences.
|
|
|
|
DowDuPont Inc.
|
Selected Financial Information and Non-GAAP Measures
|
|
|
|
Operating EBITDA by Segment
1
|
|
Three Months Ended
|
|
|
Mar 31, 2018
|
|
Mar 31, 2017
|
In millions (Unaudited)
|
|
As Reported
|
|
Pro Forma
|
Agriculture
|
|
$
|
891
|
|
|
$
|
1,461
|
|
Performance Materials & Coatings
|
|
628
|
|
|
481
|
|
Industrial Intermediates & Infrastructure
|
|
654
|
|
|
512
|
|
Packaging & Specialty Plastics
|
|
1,301
|
|
|
1,114
|
|
Electronics & Imaging
|
|
357
|
|
|
327
|
|
Nutrition & Biosciences
|
|
418
|
|
|
317
|
|
Transportation & Advanced Polymers
|
|
437
|
|
|
321
|
|
Safety & Construction
|
|
354
|
|
|
292
|
|
Corporate
|
|
(169
|
)
|
|
(211
|
)
|
Total
|
|
$
|
4,871
|
|
|
$
|
4,614
|
|
|
|
|
|
|
Equity in Earnings (Losses) of Nonconsolidated Affiliates by
Segment
2
|
|
Three Months Ended
|
|
|
Mar 31, 2018
|
|
Mar 31, 2017
|
In millions (Unaudited)
|
|
As Reported
|
|
Pro Forma
|
Agriculture
|
|
$
|
(1
|
)
|
|
$
|
4
|
|
Performance Materials & Coatings
|
|
41
|
|
|
91
|
|
Industrial Intermediates & Infrastructure
|
|
149
|
|
|
73
|
|
Packaging & Specialty Plastics
|
|
59
|
|
|
32
|
|
Electronics & Imaging
|
|
7
|
|
|
6
|
|
Nutrition & Biosciences
|
|
3
|
|
|
6
|
|
Transportation & Advanced Polymers
|
|
3
|
|
|
—
|
|
Safety & Construction
|
|
5
|
|
|
6
|
|
Corporate
|
|
(9
|
)
|
|
(10
|
)
|
Total
|
|
$
|
257
|
|
|
$
|
208
|
|
|
|
|
|
|
Reconciliation of "Income from continuing operations, net of tax"
to "Operating EBITDA"
|
|
Three Months Ended
|
|
Mar 31, 2018
|
|
Mar 31, 2017
|
In millions (Unaudited)
|
|
As Reported
|
|
Pro Forma
|
Income from continuing operations, net of tax
|
|
$
|
1,153
|
|
|
$
|
1,929
|
|
+ Provision for income taxes on continuing operations
|
|
389
|
|
|
281
|
|
Income from continuing operations before income taxes
|
|
$
|
1,542
|
|
|
$
|
2,210
|
|
+ Depreciation and amortization
|
|
1,484
|
|
|
1,368
|
|
- Interest income 3 |
|
55
|
|
|
49
|
|
+ Interest expense and amortization of debt discount
|
|
350
|
|
|
273
|
|
- Foreign exchange gains (losses), net 3, 4 |
|
(98
|
)
|
|
(85
|
)
|
- Significant items 5 |
|
(1,452
|
)
|
|
(727
|
)
|
Operating EBITDA 1 |
|
$
|
4,871
|
|
|
$
|
4,614
|
|
1.
|
|
The Company uses Operating EBITDA (for the three months ended March
31, 2018) and Pro Forma Operating EBITDA (for the three months ended
March 31, 2017), as its measure of profit/loss for segment
reporting. The Company defines Operating EBITDA as earnings (i.e.,
“Income from continuing operations before income taxes”) before
interest, depreciation, amortization and foreign exchange gains
(losses), excluding the impact of significant items. Pro Forma
Operating EBITDA is defined as pro forma earnings (i.e., pro forma
“Income from continuing operations before income taxes”) before
interest, depreciation, amortization and foreign exchange gains
(losses), excluding the impact of adjusted significant items.
|
2.
|
|
Does not exclude the impact of significant items.
|
3.
|
|
Included in "Sundry income (expense) - net."
|
4.
|
|
Excludes a $50 million pretax foreign exchange loss significant item
related to adjustments to foreign currency exchange contracts for
the change in the U.S. tax rate.
|
5.
|
|
For the three months ended March 31, 2017, significant items exclude
the impact of one-time transaction costs directly attributable to
the Merger and reflected in the pro forma adjustments.
|
|
DowDuPont Inc.
|
Selected Financial Information and Non-GAAP Measures
|
|
Significant Items Impacting Results for the Three Months Ended
Mar 31, 2018
|
In millions, except per share amounts (Unaudited)
|
|
Pretax
1
|
|
Net
Income
2
|
|
EPS
3
|
|
Income Statement Classification
|
Reported results
|
|
$
|
1,542
|
|
|
$
|
1,109
|
|
|
$
|
0.47
|
|
|
|
Less: Significant items
|
|
|
|
|
|
|
|
|
Inventory step-up amortization
|
|
(703
|
)
|
|
(618
|
)
|
|
(0.26
|
)
|
|
Cost of sales
|
Integration and separation costs
|
|
(457
|
)
|
|
(356
|
)
|
|
(0.15
|
)
|
|
Integration and separation costs
|
Restructuring and asset related charges - net
|
|
(262
|
)
|
|
(205
|
)
|
|
(0.09
|
)
|
|
Restructuring and asset related charges (credits) - net
|
Gain on sale of business/entity 4 |
|
20
|
|
|
15
|
|
|
0.01
|
|
|
Sundry income (expense) - net
|
Income tax related items 5 |
|
(50
|
)
|
|
(109
|
)
|
|
(0.05
|
)
|
|
Sundry income (expense) - net ($50 million);
Provision for income taxes on continuing operations ($71 million)
|
Total significant items
|
|
$
|
(1,452
|
)
|
|
$
|
(1,273
|
)
|
|
$
|
(0.54
|
)
|
|
|
Less: DuPont amortization of intangibles
|
|
(315
|
)
|
|
(249
|
)
|
|
(0.11
|
)
|
|
Amortization of intangibles
|
Adjusted results (non-GAAP)
|
|
$
|
3,309
|
|
|
$
|
2,631
|
|
|
$
|
1.12
|
|
|
|
|
Significant Items Impacting Pro Forma Results for the Three
Months Ended Mar 31, 2017
|
In millions, except per share amounts (Unaudited)
|
|
Pretax
1
|
|
Net
Income
2
|
|
EPS
3
|
|
Income Statement Classification
|
Pro forma results
|
|
$
|
2,210
|
|
|
$
|
1,892
|
|
|
$
|
0.81
|
|
|
|
Less: Significant items
|
|
|
|
|
|
|
|
|
Litigation related charges, awards and judgments 6 |
|
(469
|
)
|
|
(295
|
)
|
|
(0.12
|
)
|
|
Sundry income (expense) - net
|
Integration and separation costs
|
|
(242
|
)
|
|
(162
|
)
|
|
(0.07
|
)
|
|
Integration and separation costs
|
Restructuring and asset related charges - net
|
|
(152
|
)
|
|
(100
|
)
|
|
(0.04
|
)
|
|
Restructuring and asset related charges (credits) - net
|
Gain on sale of business/entity 7 |
|
162
|
|
|
86
|
|
|
0.04
|
|
|
Sundry income (expense) - net
|
Transaction costs and productivity actions
|
|
(26
|
)
|
|
(16
|
)
|
|
(0.01
|
)
|
|
Cost of sales ($23 million);
Selling, general and administrative
expenses ($3 million)
|
Income tax related items 8 |
|
—
|
|
|
100
|
|
|
0.04
|
|
|
Provision for income taxes on continuing operations
|
Total significant items
|
|
$
|
(727
|
)
|
|
$
|
(387
|
)
|
|
$
|
(0.16
|
)
|
|
|
Less: DuPont amortization of intangibles
|
|
(273
|
)
|
|
(186
|
)
|
|
(0.08
|
)
|
|
Amortization of intangibles
|
Adjusted pro forma results (non-GAAP)
|
|
$
|
3,210
|
|
|
$
|
2,465
|
|
|
$
|
1.05
|
|
|
|
1.
|
|
"Income from continuing operations before income taxes" or pro forma
"Income from continuing operations before income taxes."
|
2.
|
|
"Net income available for DowDuPont common stockholders" excluding
the impact of discontinued operations, or pro forma "Net income from
continuing operations available for DowDuPont Inc. common
stockholders." The income tax effect on significant items was
calculated based upon the enacted tax laws and statutory income tax
rates applicable in the tax jurisdiction(s) of the underlying
non-GAAP adjustment.
|
3.
|
|
"Earnings per common share from continuing operations - diluted" or
pro forma "Earnings per common share from continuing operations -
diluted."
|
4.
|
|
Includes a $20 million pretax gain related to Dow's sale of its
equity interest in MEGlobal.
|
5.
|
|
Related to effects of U.S. Tax Reform. Impacts include a $50 million
pretax foreign exchange loss ($38 million after-tax) related to
adjustments to foreign currency exchange contracts for the change in
the U.S. tax rate.
|
6.
|
|
Pretax charge for Dow AgroSciences' arbitration matter with Bayer
CropScience.
|
7.
|
|
Related to the sale of DuPont's global food safety diagnostics
business.
|
8.
|
|
Related to a reduction in DuPont's unrecognized tax benefits and
reversal of associated interest, due to the closure of various tax
statutes of limitations.
|
View source version on businesswire.com:
https://www.businesswire.com/news/home/20180503005642/en/
DowDuPont
Investors:
Greg Friedman
greg.friedman@dupont.com
+1
302-774-4994
or
Neal Sheorey
nrsheorey@dow.com
+1
989-636-6347
or
Media:
Rachelle Schikorra
ryschikorra@dow.com
+1
989-638-4090
or
Dan Turner
daniel.a.turner@dupont.com
+1
302-996-8372
Source: DowDuPont